MetaCap

electroCore (ECOR) vs Precision Optics (POCI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

electroCore (ECOR) has outperformed Precision Optics (POCI) over the past year, losing 6.2% versus a loss of 10.4%. Over five years, POCI leads with a -37.9% price change compared with -61.2% for ECOR. Precision Optics is the larger company by market cap ($45.3 million vs $40.8 million), about 1.1 times the size.

Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -43.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ECOR-6.16%POCI-10.43%
+170%+73%-24%
Nov 21, 20251 yearNov 20, 2026
ECOR-61.13%POCI-39.23%
+62%-8%-77%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ECOR versus POCI key metrics
MetricECORPOCI
Share price$4.42$4.12
Market cap$40.78M$45.30M
1-day change-8.87%+1.41%
YTD return-1.45%-1.67%
1-year return-6.16%-10.43%
5-year return-61.23%-37.86%
Forward P/E—206.00
EPS (TTM)$-1.36$-0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$32.03M$31.53M
Revenue growth (YoY)+27.20%+65.16%
Net income (latest FY)$-13.97M$-3.63M
Gross margin86.75%17.22%
Operating margin-41.06%-11.13%
Net margin-43.60%-11.51%
52-week high$12.70$6.15
52-week low$3.90$3.55
Distance from 52-week high-65.20%-33.01%
Analyst consensusnonestrong_buy
Avg. price target upside+333.71%+94.17%
Average volume120.32K43.00K
Shares outstanding9.23M10.99M
Employees83108
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -43.6 cents for electroCore.
  • Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs +27.20%).

About electroCore

ECOR stock →

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees

About Precision Optics

POCI stock →

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees

ECOR vs POCI FAQ

Which is bigger, electroCore or Precision Optics?

Precision Optics (POCI) is larger, with a market capitalization of $45.30M compared with $40.78M for electroCore (ECOR).

Which stock has performed better over the past year, ECOR or POCI?

ECOR returned -6.16% over the past 12 months, compared with -10.43% for POCI (price return, excluding dividends). Past performance does not predict future results.

Are electroCore and Precision Optics in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons